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Abstract
Pericardial fat is a localized fat depot associated with coronary artery calcium and myocardial infarction. We hypothesized
that genetic loci would be associated with pericardial fat independent of other body fat depots. Pericardial fat was
quantified in 5,487 individuals of European ancestry from the Framingham Heart Study (FHS) and the Multi-Ethnic Study of
Atherosclerosis (MESA). Genotyping was performed using standard arrays and imputed to ,2.5 million Hapmap SNPs. Each
study performed a genome-wide association analysis of pericardial fat adjusted for age, sex, weight, and height. A weighted
z-score meta-analysis was conducted, and validation was obtained in an additional 3,602 multi-ethnic individuals from the
MESA study. We identified a genome-wide significant signal in our primary meta-analysis at rs10198628 near TRIB2 (MAF
0.49, p=2.7610
-08). This SNP was not associated with visceral fat (p=0.17) or body mass index (p=0.38), although we
observed direction-consistent, nominal significance with visceral fat adjusted for BMI (p=0.01) in the Framingham Heart
Study. Our findings were robust among African ancestry (n=1,442, p=0.001), Hispanic (n=1,399, p=0.004), and Chinese
(n=761, p=0.007) participants from the MESA study, with a combined p-value of 5.4E-14. We observed TRIB2 gene
expression in the pericardial fat of mice. rs10198628 near TRIB2 is associated with pericardial fat but not measures of
generalized or visceral adiposity, reinforcing the concept that there are unique genetic underpinnings to ectopic fat
distribution.
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Introduction
Obesity is a heterogeneous condition, and its attendant
metabolic sequelae may not be adequately captured by using
traditional metrics of generalized adiposity [1]. In part, this is
because different fat depots may be associated with differential
metabolic risk. For example, visceral abdominal fat is thought to
be a unique pathogenic fat depot [2,3].
PLoS Genetics | www.plosgenetics.org 1 May 2012 | Volume 8 | Issue 5 | e1002705Ectopic fat depots, defined as fat depots in non-classical
locations [4], may mediate vascular disease due to their local
toxic effect on nearby anatomic structures. We and others have
shown that pericardial fat, defined as fat surrounding the heart and
attendant structures, but not visceral fat, is associated with
coronary artery calcification and coronary heart disease [5,6].
The hypothesized local toxic effect of pericardial fat is supported
by experimental research demonstrating perivascular inflamma-
tion [7] and smooth muscle cell proliferation [8].
Prior studies have shown that measures of generalized adiposity,
including body mass index, are heritable [9]. In addition, more
recent work has demonstrated that markers of body fat distribu-
tion, including waist-hip-ratio [10], subcutaneous and abdominal
visceral fat [3], and fatty liver [11] also have a heritable
component. Recent large scale genome-wide association studies
(GWAS) have identified genomic loci for indices of body fat
distribution that are independent of BMI [11–13], further
supporting the concept that unique genetic variants exist that
are associated with ectopic fat depots. To explore this further, we
conducted a GWAS of pericardial fat to determine whether
genetic loci are associated with the propensity to store fat around
the heart.
Results
Study Sample Characteristics
The study sample characteristics are shown in Table 1 and
Table S1. The mean age ranged from 55 years in the Framingham
Heart Study to 62 years in MESA. In the MESA cohort, mean
pericardial fat differed significantly between race/ethnicity groups.
Compared to European Americans, mean pericardial fat was
significantly lower in African Americans (P=1.1E-38) and
Chinese Americans (P=4.8E-11), and was higher in Hispanic
Americans (p=0.02).
Heritability Analyses and Genetic Correlations
The heritability (h2) of pericardial fat in the Framingham Heart
Study was 50%. Upon additional adjustment for height and
weight, the h2 was 52%.
We also calculated genetic correlations between pericardial fat,
visceral fat (VAT), and BMI in the Framingham Heart Study.
Genetic correlations between pericardial fat and VAT were 0.57;
between pericardial fat and BMI 0.41, and between VAT and
BMI 0.75. In all cases, we confirmed that there are genes that are
associated with pair-wise comparisons of all three traits (all p-
values,1.7*10E-15 for overlapping genetic correlations), although
our results also suggest that not all genes are shared (all p-
values,1.4*10E-22 for non-overlapping genetic correlations).
GWAS Results of Meta-Analysis of the Framingham Heart
Study and the MESA Study
The quantile-quantile plot (Figure S1) of GWAS of 5487
individuals of European ancestry demonstrated deviation from the
null with no evidence of population stratification (lambda 0.99).
The Manhattan plot (Figure S2) shows a genome-wide significant
locus on chromosome 2 (p=2.7E-08). The lead SNP (MAF 0.49)
is rs10198628 located ,80 kb upstream from the TRIB2 gene. Per
copy of the A allele, pericardial fat volumes were 4.4 cm
3 lower in
the Framingham Heart Study and 3.6 cm
3 lower in MESA. All
SNPs with p-values,1E-04 are shown in Table S2. We observed
no evidence for a sex interaction for rs10198628 (p=0.33). The
variance of pericardial fat explained by the lead SNP in the
Framingham Heart Study was 0.5% and 0.3% in MESA.
Stage 2 Validation
We performed validation in a multi-ethnic sample of African
ancestry (n=1442, b=3.31, p=0.001), Hispanic (n=1399,
b=3.62, p=0.004), and Chinese (n=761, b=4.56, p=0.007)
participants from the MESA study, with a combined Stage 1 and
Stage 2 p-value of 5.4E-14 (Figure 1A and Figure 1B).
Associations with Other Fat Depots
To assess whether rs10198628 is specific to pericardial fat, we
assessed its associations with other fat depots (Table 2). We
observed no association with body mass index from the GIANT
consortium (p=0.38) [14] or with visceral or subcutaneous fat
from the Framingham Heart Study (p=0.17 and 0.34, respec-
Table 1. Study sample characteristics.
Study n Women % (n) Age (years) BMI (kg/m2) Pericardial Fat (cm3)
Framingham Heart Study 3100 48 55.4(11.8) 27.8(5.3) 113.6(44.7)
MESA study
European Ancestry 2519 52 (1317) 62.7 (10.2) 27.7 (5.1) 85.3 (46.2)
African Ancestry 1609 54 (868) 62.3 (10.1) 30.1 (5.9) 68.0 (34.6)
Chinese 768 51 (390) 62.4 (10.4) 24.0 (3.3) 74.1 (31.6)
Hispanic 1445 52 (746) 61.4 (10.3) 29.4 (5.1) 88.6 (43.7)
Data shown as mean (standard deviation) unless otherwise indicated.
doi:10.1371/journal.pgen.1002705.t001
Author Summary
Pericardial fat is a localized fat depot associated with
coronary artery calcium and myocardial infarction. To test
whether genetic loci are associated with pericardial fat
independent of other body fat depots, we measured
pericardial fat in 5,487 individuals of European ancestry.
After performing an unbiased screen using genome-wide
association, we identified a genome-wide significant signal
in our primary meta-analysis at rs10198628 near TRIB2
(MAF 0.49, p=2.7610
-08). This SNP was not associated with
visceral fat (p=0.17) or body mass index (p=0.38). Our
findings were robust among multi-ethnic participants from
the MESA study, with a combined p-value of 5.4E-14. We
observed TRIB2 gene expression in the pericardial fat of
mice. rs10198628 near TRIB2 is associated with pericardial
fat but not measures of generalized or visceral adiposity,
reinforcing the concept that there are unique genetic
underpinnings to ectopic fat distribution.
Pericardial Fat GWAS
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waist-hip-ratio adjusted for body mass index from the GIANT
consortium (p=0.01) [12] and with visceral fat adjusted for body
mass index in the Framingham Heart Study (p=0.01).
Associations of Previously Published Loci for Body Fat
Distribution and BMI with Pericardial Fat
We tested whether previously published SNPs in association
with waist-hip-ratio adjusted for BMI [12] and BMI [14] are
associated with pericardial fat in our meta-analysis dataset (Tables
S4 and S5). Among the 14 well-validated SNPs for body fat
distribution, we observed direction-consistent associations with
CPEB4, a gene involved in cell survival [15]. Among SNPs
associated with BMI, we observed nominal direction-consistent
associations with FTO; no other associations were observed.
Associations with Subclinical Atherosclerosis and
Cardiovascular Disease Traits
Because of the proposed locally toxic effect of pericardial fat and
cardiovascular disease outcomes, we evaluated the association of
rs10198628 with several CVD phenotypes. We observed nominal,
Figure 1. Regional association plots of rs10198628 in MESA ancestry populations. European, African (A), Chinese, and Hispanic ancestry
population (B).
doi:10.1371/journal.pgen.1002705.g001
Table 2. Results for rs10198628 across body composition and
atherosclerosis traits in the Framingham Heart Study
(n=3,158) and the GIANT Consortium (n=77,157 to 133,828)
modeled per copy of the A allele.
Trait Source n Beta* P-value
Subcutaneous adipose tissue FHS 3182 20.025 0.34
Visceral adipose tissue FHS 3158 20.036 0.17
Visceral adipose tissue adj BMI FHS 3146 20.065 0.010
Visceral/Subcutaneous fat ratio FHS 3158 20.019 0.47
Body mass index GIANT 123854 neg 0.38
Waist hip ratio adjusted BMI GIANT 77157 neg 0.01
Height GIANT 133828 neg 0.61
Carotid intimal medial thickness MESA 2505 20.051 0.04
Coronary Artery Calcium MESA 2527 0.056 0.25
Coronary Heart Disease CARDIoGRAM 819292 1.01 0.37
*Odds ratio presented for CARDIoGRAM.
doi:10.1371/journal.pgen.1002705.t002
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thickness from the MESA individuals of European ancestry
(n=2505, p=0.04), but we observed no association with
myocardial infarction from the CARDIoGRAM consortium
(p=0.37, OR 1.01 [95% CI 0.985–1.04], n=81929) [16] or with
coronary artery calcification from the MESA study (p=0.25,
n=2527).
Association of Validated Coronary Heart Disease SNPs in
the Pericardial Fat GWAS
We performed a look-up of 25 validated SNPs for coronary
heart disease from the CARDIoGRAM consortium (Table S3)
[16], and found that rs12190287 at TCF21 was associated with
pericardial fat in a direction-consistent fashion (p=0.0019). No
additional SNPs met the bonferroni corrected p-value threshold of
p,0.002 (0.05/25).
Gene Expression
We queried available human gene expression genetics data (see
Methods) and identified eQTL associations with TRB2 in omental
adipose (rs890069, 1.79e-9) [42] and two independent subcutane-
ous adipose samples (rs4669887, 3.62e-9; rs12616457, 1.28e-6)
[41,42]. All of these variants are in LD with our lead SNP
rs10198628 (rs890069, rs4669887, rs1261657 have r2 0.38, 0.38
and 0.51 with rs10198629, respectively).
Next, we tested for gene expression in multiple subcutaneous
(inguinal, axillary, and gluteal) and visceral (epididymal, retroper-
itoneal, mesenteric, omental) adipose depots as well as classical
brown, pericardial, and perivascular adipose tissue which were
dissected from high-fat fed male mice. mRNA expression levels of
the adipocyte markers aP2 and PPARc2 were comparable across
all adipose depots. Trib2 was expressed in pericardial adipose
tissue, as well as all of the other adipose depots surveyed (Figure
S3). Expression in pericardial adipose tissue was comparable to
that in other adipose depots. Lipin 1 is another annotated gene
near our lead SNP. It was also expressed in pericardial adipose
tissue, as well as all other depots surveyed. Furthermore,
expression in pericardial adipose tissue was comparable to that
in other adipose depots.
Discussion
Principal Findings
We have identified a SNP near the TRIB2 locus that is
associated with pericardial fat but not with body mass index or
visceral abdominal fat. This SNP is also associated with pericardial
fat in a multi-ethnic sample consisting of individuals of European,
African, Hispanic, and Chinese ancestry. Finally, we identified a
nearby eQTL, suggesting the potential for altered gene expression
associated with our top SNP, or a correlated variant.
An important question of our work is whether rs10198628 is
uniquely associated with pericardial fat, or merely represents a
manifestation of generalized adiposity. Our results suggest that this
SNP is unique in its association with pericardial fat, given its strong
association with pericardial fat in our stage 1 and stage 2 analysis.
In contrast, this SNP was not associated with visceral abdominal
fat, an ectopic fat depot that is correlated with pericardial fat.
Further, we observed no association with our lead SNP and body
mass index in more than 100,000 individuals from the GIANT
consortium. We note that we observed nominal significance with
our lead SNP with VAT-adjusted-for-BMI and waist-hip-ratio-
adjusted for BMI, traits representing fat distribution.
Gene expression analysis in mice showed that Trb2 is expressed
in all adipose depots. Expression was not enriched in any depot.
Confirmation that Trb2 is expressed in adipose tissue supports a
functional role for this gene product in this tissue. Future studies
are needed to investigate the specific function of Trb2 in adipose
tissue, and in particular in pericardial fat. Finally, although our
lead SNP is closest to Trb2, it is also possible that this is part of a
regulatory region for another gene.
In the Context of the Current Literature
Prior genome-wide association studies have primarily used
easily-obtainable anthropometric measurements to estimate body
fat distribution [12,13]. While these studies benefit from concom-
itant enhanced power, the lack of detailed phenotyping renders the
precise meaning of the measurement uncertain. In the current
study, we have made use of well-validated measurements of
pericardial fat that have been previously associated with coronary
artery calcium [5,17], myocardial infarction [6,18], measurements
of left ventricular structure and function [19], and carotid intimal
medial thickness [20]. In this context, we sought to examine our
lead SNP with coronary calcium, coronary heart disease, and
carotid intimal medial thickness. Given the modest epidemiologic
associations that have been observed in concert with the relatively
small genetic effect sizes that are typical of GWAS, it is not
surprising that we observed only nominal associations with carotid
intimal medial thickness.
Our findings are also notable for some enrichment of association
with a SNP in TCF21, previously identified in association with
coronary heart disease in CARDIoGRAM [16]. TCF21 encodes a
transcription factor of the basic helix-loop-helix family and is a
molecular marker of white adipose tissue [21]. TCF21 is expressed
in the epicardium of the developing zebrafish, and is associated with
perivascular cellsbutnot cardiomyocytes[22].Thisisrelevant given
the anatomic location of pericardial fat and thus rendering it a form
of perivascular fat surrounding the coronary arteries.
Potential Mechanisms
Our lead SNP is located about 80 kb downstream from TRIB2.
TRIB2 is the tribbles homolog 2 gene, part of the Tribbles gene
family. TRIB2 expression has been shown to be elevated in lung
cancer, and has been found to induce apoptosis through
downregulation of the transcription factor CCAAT/enhancer-
binding protein alpha (C/EBPa) [23]. Via this mechanism, TRIB2
may also suppress adipocyte differentiation via AKt inhibition and
C/EBPa degradation [24]. TRIB2 has also been associated with
hematologic abnormalities including acute myelogenous leukemia
[25]. TRIB2 has also been shown to be a regulator of the
inflammatory activity of monocytes [26], suggesting a possible
mechanism by which it may link low density lipoprotein
cholesterol to plaque formation. TRB1 and TRB3 have both been
linked to obesity and related phenotypes, with TRIB1 gene
expression linked to adipose tissue inflammation [27] and TRB3
gene expression associated with insulin resistance [28].
Our lead SNP also lies near the LPIN1 gene, a compelling
candidate gene that has previously been identified in association
withlipodystrophysyndromes [29]. While it is temptingto implicate
this gene in our association analyses, it is notable that only rare, not
common variants have been detected in human populations in
association with lipodystrophic phenotypes [30]. In addition, our
best SNP in the LIPN1 gene has a p-value=0.03, rendering it less
likely. Finally, our lead SNP is ,1 MB from LPIN1.
Strengths and Limitations
Strengths of our study include the well-characterized pericardial
fat data present in both the Framingham Heart Study and the
MESA Study. An additional strength is the extension of our
Pericardial Fat GWAS
PLoS Genetics | www.plosgenetics.org 4 May 2012 | Volume 8 | Issue 5 | e1002705findings to multi-ethnic populations, underscoring the generaliz-
ability of this finding. Typical of GWAS, we have identified an
associated locus, but the causal variant and gene remains
unidentified. Limitations include the relatively modest sample size
of our study, leading to relatively low power to detect small effects.
While our finding that rs12190287 at TCF21 was associated with
pericardial fat in a direction-consistent fashion, we are unable to
perform a formal mediation analysis.
Implications
These findings support the concept that unique genetic variants
exist in association with different ectopic fat depots. These findings
are important because they suggest that different ectopic fat depots
may each have their own unique genetic signature that is
independent of generalized adiposity. Future work should focus
on identifying the molecular mechanisms that link these genomic
loci to ectopic fat depots, as this could ultimately lead to the
identification of novel pathways and new therapeutic targets.
Conclusions
A SNP near TRIB2 is associated with pericardial fat but not
measures of generalized or visceral adiposity, reinforcing the
concept that there are unique genetic underpinnings to ectopic fat
distribution.
Methods
Phenotype Definition
Pericardial fat was measured on CT using protocols determined
by the participating studies, as described in the Study-Specific
Methods. Sex-specific residuals were created, with adjustment for
age, height, and weight, as well as principal components derived
from genotypes denoting population stratification where necessary.
Heritability Analyses
Heritability of pericardial fat was calculated in the Framingham
Heart Study using standard methods. Sex-and-cohort specific
residuals were created and then pooled for analysis using variance
components analysis (SOLAR) [31].
Genetic Correlations with Other Adiposity Traits
We used SOLAR [31] to calculate pair-wise genetic correlations
between pericardial fat, visceral fat, and BMI in the Framingham
Heart Study. We used residuals adjusted for age and sex. We
tested two separate hypotheses: RhoG=0 is the test for
overlapping genetic correlations, whereas RhoG=1 is the test
for non-overlapping genetic correlations.
Discovery Analyses
Table S1 and the study specific methods describe the
genotyping that was conducted. Quality-control filters were used
to exclude low-quality samples or SNPs. Each study imputed ,2.5
million Phase 2 HapMap SNPs based on CEU samples; allelic
dosage was used in the analysis.
Each cohort separately conducted the regression analysis, using
an additive genetic effectmodel with accountingfor family structure
when necessary. Next, we conducted a fixed effects weighted Z-
score meta-analysis given possible differences in phenotype scaling
between the participating studies using METAL [32]. Statistical
significance was considered when SNPs reached a meta-analysis P
value#5610
28 [33]. Discovery analyses were performed on
European ancestry participants. SNPs were filtered at a minor
allele frequency,2% and an imputation quality score,0.3.
Stage 2 Analysis
We conducted Stage 2 validation using non-white ethnic
samples from the MESA study. Statistical significance was
achieved when a direction-consistent p-value was at least p,0.05.
Analyses of Related Phenotypes
For our lead SNP, we performed look-up in the publically
available GIANT datasets [12,14]. We also obtained specific look-
up results in the CARDIoGRAM (for coronary heart disease) [16]
and MESA (for coronary artery calcification and carotid intimal
medial thickness).
We also tested whether the 25 previously-identified SNPs for
coronary heart disease from the CARDIoGRAM consortium [16]
were associated with pericardial fat. To determine statistical
significance, we used the false discovery rate q-value; SNPs with q-
value,0.05 were considered statistically significant using the
QVALUE package in R [34].
Interaction Testing
We tested for a formal sex interaction of rs10198628. Each study
computed the interaction regression coefficient, standard error, and
p-value. For the sex interaction, we included, age, height, weight,
and any principal components (and study center) that were used in
the original discovery analysis. We additionally added rs10198628
and the cross-product rs10198628*sex. Interaction terms were
meta-analyzed using the weighted z-score approach.
Variance Explained
We calculated the variance explained using the following
formula: 2*MAF*(12MAF)*(((beta)‘2)/((SD)‘2)).
eSNP Analysis
We searched for eQTLs in a region bounded by the LIPN1
and TRIB2 genes using expression SNP (eSNP) datasets availably
publically or via collaboration including lymphocytes [35],
leukocytes [36], leukocytes from patients with Celiac disease
[37], lymphoblastoid cell lines (LCL) from children with asthma
[38], HapMap LCL from 3 populations [39], a separate study on
HapMap CEU LCL [40], peripheral blood monocytes [41,42],
subcutaneous and omental adipose tissue [43,44], and blood
samples [43], 2 studies on brain cortex [41,45], three large studies
of brain regions including prefrontal cortex, visual cortex and
cerebellum (Emilsson, personal communication), liver [44,46],
osteoblasts [47], skin [48], and additional fibroblast, T cell and
LCL samples [49]. Statistical significance was considered using the
association with gene transcript levels as originally described.
Gene Expression
Adipose tissue was dissected from male C57Bl/6J mice (Jackson
Labs) (n=4) following 20 weeks of ad libitum feeding with a 60%
high-fat diet (Research Diets, New Brunswick NJ). High fat feeding
was used because many adipose depots (such as pericardial fat) are
either not visible or extremely limited in size in standard chow fed
mice. Animals were sacrificed and adipose tissues were dissected
and frozen in liquid nitrogen. The following adipose depots were
dissected: inguinal, axillary, gluteal, brown adipose, epididymal,
retroperitoneal, mesenteric, omental, pericardial, and perivascu-
lar. All animal experiments were done according to procedures
approved by the Institutional Animal Care and Use Committee of
Beth Israel Deaconess Medical Center.
Total RNA was isolated using TRIzol (Invitrogen, Carlsbad, CA)
combined with RNeasy mini-columns, (Qiagen, Valencia, CA)
according to the manufacturer’s instructions. For real-time PCR
Pericardial Fat GWAS
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cDNA synthesis kit (ABI, Carlsbad, CA). cDNA was used in
quantitative PCR containing SYBR-green dye (ABI). mRNA
expression levels for each gene were normalized to TBP.Quantitative
PCR was performed using an ABI-7900HT PCR machine.
In addition to Lipin 1 and Trb2, the expression of the adipocyte
markers aP2 and PPARc2 were also measured. The primer
sequences were as follows: aP2, forward 59 CAT CAG CGT AAA
TGG GGA TT 39 reverse 59 CCG CCA TCT AGG GTT ATG
AT 39; Lipin 1, forward 59 CGT ACG TGC GGC TCT GCG
AA 39 reverse 59 GCT CGG TCG CGT CAA GCT GA 39;
PPARc2, forward 59 GCA TGG TGC CTT CGC TGA 39
reverse 59 TGG CAT CTC TGT GTC AAC CAT G 39; TBP,
forward 59 CCC CTT GTA CCC TTC ACC AAT 39 reverse 59
GAA GCT GCG GTA CAA TTC CAG 39; Trib2, forward 59
CCC GCC CGA GAC TCC GAA CT 39 reverse 59 GCA CAG
CGC GGA AAA CGT GG 39.
Study-Specific Information
Framingham Heart Study. The Framingham Heart Study
began in 1948 with the enrollment of the Original Cohort [50]. In
1971, the 5,124 participants were enrolled as part of the Offspring
Cohort. Finally, in 2002, the Third Generation cohort was
enrolled (n=4095) [51]. Participants for the present study were
derived from the Framingham Heart Study Multi-detector
Computed Tomography (MDCT) Sub-Study. Briefly, from June
2002 to April 2005, 3529 participants (2111 Third Generation,
1418 Offspring participants) underwent MDCT.
Framingham Heart Study participants underwent MDCT
utilizing 8-slice MDCT in a supine position (LightSpeed Ultra,
General Electric, Milwaukee, WI). On average, 48 contiguous
2.5 mm slices of the heart were acquired with prospectively ECG
triggered CT scanning protocol (120 kVp, 400 mA, temporal
resolution 330 ms).
We measured pericardial fat tissue volumes (cm
3) with a
dedicated offline workstation (Aquarius 3D Workstation, TeraR-
econ Inc., San Mateo, CA) based on the principle that absolute
Hounsfield Units (HU) values correspond to tissue property. Thus,
we set a predefined image display (window width 2195 to 245
HU; window center 2120 HU) to identify pixels that correspond
with adipose tissue. Pericardial fat was measured across the
complete available imaging volume in cm
3.
We used a semi-automatic segmentation technique which required
the reader to manually trace the pericardium. We defined pericardial
fatvolumeasadiposetissuelocatedwithinthepericardialsac.Usinga
random sample of 100 participants, intra-reader (ICC 0.97) and
inter-reader (ICC 0.95) reproducibility was excellent [5].
Framingham Heart Study participants also underwent eight-
slice MDCT imaging of the abdomen with twenty-five contiguous
five mm thick slices (120 kVp, 400 mA, gantry rotation time
500 ms, table feed 3:1) acquired 125 mm beyond the level of S1.
Subcutaneous and visceral adipose tissue volumes (SAT and VAT)
were assessed as previously described, with excellent inter-class
correlations for VAT (0.992) and SAT (0.997) [52].
The Phase II CEU HapMap panel was used a reference to
impute genotypes to roughly 2.5 million HapMap SNPs; details
can be found in Table S1. MACH v1.0.15/16 (http://www.sph.
umich.edu/csg/abecasis/MACH/) was used along with 200 (101
Men and 99 Women) biologically independent individuals in order
to establish parameter estimates. We then used these estimates to
infer gene dosage. Imputed genotypes were expressed as allelic
dosage (which is a decimal value ranging from 0–2).
Linear mixed effects regression modeling was used in order to
account for pedigree structure (R lme and kinship package). Given
that we observed association with the first principal component
(estimated using Eigenstrat [53]), we included this component in
our regression models.
MESA. The Multi-Ethnic Study of Atherosclerosis (MESA) is a
National Heart, Lung and Blood Institute-sponsored, population-
based investigation of subclinical cardiovascular disease and its
progression [54]. In brief, a total of 6,809 individuals, aged 45 to
84 years, were recruited from six US communities (Baltimore City
and County, MD; Chicago, IL; Forsyth County, NC; Los Angeles
County, CA; New York, NY; and St. Paul, MN) between July
2000 and August 2002.
All MESA participants underwent baseline cardiac CT scans at
baseline, which were analyzed for pericardial fat volume (cm3).
Cardiac CT scans were performed either with an ECG-triggered
(at 80% of the RR interval) electron-beam scanner (Chicago, Los
Angeles, and New York field centers; Imatron C-150, Imatron) or
with prospectively ECG-triggered scan acquisition at 50% of
the RR interval with a multidetector system that acquired 4
simultaneous 2.5-mm slices for each cardiac cycle in a sequential
or axial scan mode (Baltimore, Forsyth Country, and St. Paul field
centers; Lightspeed, General Electric or Volume Zoom, Siemens).
Three experienced CT analysts measured pericardial fat volume
on the previously obtained images of the heart. For pericardial fat
volume, slices within 15 mm above and 30 mm below the superior
extent of the left main coronary artery were included. This region
of the heart was selected because it includes the pericardial fat
located around the proximal coronary arteries (left main coronary,
left anterior descending, right coronary, and circumflex arteries).
The anterior border of the volume was defined by the chest wall
and the posterior border by the aorta and the bronchus. Volume
Analysis software (GE Healthcare, Waukesha, WI) was used to
discern fat from other tissues with a threshold of 2190 to 230
Hounsfield units. The volume was the sum of all voxels containing
fat. Our measure of pericardial fat volume was highly correlated
with total volume of pericardial fat volume in a random subset of
10 Diabetes Heart Study participants (correlation coefficient: 0.93;
p,0.0001). A random sample of 80 MESA participants was
selected and their CT scans were reread. The intra-class
correlation coefficients of intra-reader and inter-reader reliability
were 0.99 and 0.89 for pericardial fat [6].
Coronary artery calcium was also assessed using the cardiac CT
scans at baseline [55]. Briefly, we used the reader–work station
interface to calibrate each tomographic image according to the
estimated attenuation of the calcium phantom and then identified
and quantified the coronary calcium in each image. We than
calculated the coronary calcium score (Agatston score) for each
scan. Intraobserver and interobserver agreement was excellent
(kappa statistics, 0.93 and 0.90, respectively).
Carotid intimal medial thickness (IMT) measures were obtained
at baseline using ultrasound imaging of the carotid arteries that
was performed using a GE scanner. Using videotaped scans, we
performed a centralized interpretation of the data. IMT was
measured between lumen-intima and media-adventitia interfaces
of near and far walls of the common carotid artery (the 1 cm
segment proximal to the bifurcation) and the internal carotid
artery (including the bifurcation and 1 cm distal to the bifurca-
tion). A maximum IMT for each of these two segments was
standardized (by subtraction of the MESA population mean and
division by its standard deviation), and the mean of the
standardized IMT for the common and the internal carotid
maxima was used in analysis [56].
MESA participants provided consent for genotyping and had
DNA extracted at the time of baseline enrollment between 2000–
2002. Genotyping was performed at the Broad Institute of
Pericardial Fat GWAS
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Affymetrix Laboratory (Santa Clara, CA, USA) using the
Affymetric Genome-Wide Human SNP Array 6.0 (Affymetrix,
Santa Clara, California, USA). Genotype results were imputed to
2.5 million SNPs using IMPUTE v.2.1.0 software (http://
mathgen.stats.ox.ac.uk/impute/impute.html) [57]. Participant-
specific quality controls included filters for call rate and number
of Mendelian errors per individual. SNP-specific quality controls
included filters for call rate and heterozygosity.
Linear regression modeling was used with adjustment for age,
sex, weight, and height. The first principal component (estimated
using Eigenstrat [53]) was included in our regression models.
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